Clinical Trial Investigator: Tanya Simuni, MD
Aim: To determine whether 1mg/day of Rasagiline is more effective than placebo in improving cognitive function in patients with mild cognitive impairment (MCI) in Parkinson's Disease (PD-MCI).
Procedures: Treatment with either Rasagiline or placebo
Study Duration: 24 weeks
Travel Compensation: $15 per visit
ALL STUDY RELATED MEDICATION/PROCEDURES ARE FREE OF CHARGE.
For More Information: Call us at (312) 503-0755, or email email@example.com.
Northwestern Medicine and Northwestern University Feinberg School of Medicine will not release any of your personal information to 3rd parties, participating organizations and/or other institutions. Your information will only be available to the researcher(s) after you indicate interest in being contacted about a particular study.
Newly diagnosed with Parkinson’s disease and not yet treated? Please complete the Northwestern Medicine Parkinson’s Disease and Movement Disorders Center online appointment form to discuss next steps.
Feinberg is not a site of care. PDMDC faculty see patients through our affiliated clinic.